Meta Pixel


Access Curated Private Market Opportunities

Award-winning Platform Empowering Innovation, Capital and Ambition, Globally

  • 0 +

    Investors & Deal Makers

  • 0

    Unicorns

  • 0

    Year track record

Homepage

POWERED BY CapitalHQTM

Utilise our cutting-edge AI-powered platform to access curated Private Opportunities. Discover Startups, Scaleups, Fund Managers, Private Equity, Property, Small Cap Listed and Secondary Market Opportunities

Join an exclusive ecosystem of High-Net-Worth, Professional, Institutional, VC and Family Office Investors. Receive personalised deal flow, streamlined information access and access to investment insights from leading global Fund Managers and Investors

Access Exclusive Private Opportunities

Get access to curated growth companies, property opportunities, alternative funds, investment insights and exclusive investor networking events

  • Free Account Set up
  • No transaction fees
  • Direct Access to CEOs and Managers
  • Curated Global Deal Flow

QBiotics Group

Pharmaceuticals

The Insides Company

Medical Devices

Medigrowth – Equity

Medicinal Cannabis

Cortical Dynamics

Healthtech

Bioshore Ventures

Medical Devices

NanoFynd Pty Ltd

Biotechnology

Navi Medical Technologies

Medical Devices

Elemental IV

Pharmaceuticals

SoHi Partners

Medical Devices

A Personalised Pipeline of Opportunities

Let our AI/ML provide you with personalised, exclusive and consistent deal flow

QBiotics Group

Pharmaceuticals

The Insides Company

Medical Devices

Medigrowth – Equity

Medicinal Cannabis

Cortical Dynamics

Healthtech

Bioshore Ventures

Medical Devices

NanoFynd Pty Ltd

Biotechnology

Navi Medical Technologies

Medical Devices

Elemental IV

Pharmaceuticals

SoHi Partners

Medical Devices
  • Overview
  • Market Opportunity
  • Competitive Advantage
  • Highlights and Milestones
  • Investment Offering

Streamlined Investor Experience

Access the information you want and need, in a structured, clear format.

Trusted by hundreds of companies worldwide

Our international clientele includes leading emerging growth companies, funds, governments, universities, incubators, accelerators and advisory firms.

Premier Investor Events and Conferences

See exclusive pitches, product demos, and talk with founders
In person or online

EMERGENCE – Investment Conference – Dubai 2026

01-02 Apr 2026
Learn More

3rd Annual CapitalHQ Online Investment Showcase

09 Apr 2026
Learn More

News and announcements

Our Clients’ Major Breakthrough and Milestones

Capital Insights
Wholesale Investor Tests Explained: Net Assets, Income & Product Value

Wholesale Investor Tests Explained Australian law provides multiple pathways for qualifying as a wholesale investor. Each test has different criteria, documentation requirements, and practical implications. This guide provides a detailed breakdown of every qualification test, the evidence required, and the common pitfalls to avoid. Test 1: The Net Assets Test What It Requires Net assets […]

Capital Insights
Do I Qualify as a Wholesale Investor? The Complete Self-Assessment

Do I Qualify as a Wholesale Investor? If you are considering investing in private markets in Australia, the first question you need to answer is whether you qualify as a wholesale (or sophisticated) investor. The qualification criteria are set out in the Corporations Act 2001 and are based on financial thresholds rather than investment knowledge […]

Capital Insights
How to Become a Wholesale Investor in Australia [2026 Guide]

How to Become a Wholesale Investor in Australia Becoming a wholesale investor in Australia is not a matter of applying to a regulatory body or passing an exam. It is a classification that flows from meeting specific financial thresholds outlined in the Corporations Act 2001 (Cth). If you meet the criteria, you can be certified […]

Capital Insights
Wholesale Investor vs Retail Investor: Key Differences Explained

Wholesale Investor vs Retail Investor: What is the Difference? In Australia, every investor is classified as either retail or wholesale under the Corporations Act 2001. This classification determines which investment products you can access, what level of regulatory protection you receive, and what disclosure obligations apply to the issuers of the products you invest in. […]

See more exiting opportunities on CapitalHQ

Pictor

Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,…

flag_new zealand
New Zealand NZD
Biotechnology Series B+

ProxyTwin

ProxyTwin™ amplifies expertise. ProxyTwin is a digital twin that works for experts so they can help more people. We create advanced digital replicas of real individuals, enabling them to virtually attend meetings, deliver messages, and hold thousands of interactions simultaneously. Recently…

flag_australia
Australia AUD
Artificial Intelligence Seed Round

HorizonTwo Capital Partners

HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.

flag_australia
Australia AUD
Advanced Manufacturing Private Placement

The Insides Company

First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.

flag_new zealand
New Zealand AUD
Medical Devices Series A

DCARB

We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.

flag_australia
Australia CAD
Green Hydrogen Series B+

Grabba Technologies Pty Ltd

Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.

flag_australia
Australia AUD
Electronic Equipment & Instruments Private Placement

Join over 45,000+ sophisticated investors

Join Now